Mechanism of action of aspirin-like drugs

Seminars in Arthritis and Rheumatism

Volumn 26, Issue 6 SUPPL. 1, 1997, Pages 2-10

  Vane, J R ^a   Botting, R M ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cyclooxygenase; NSAIDs; Prostaglandins

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; IBUPROFEN; INDOMETACIN; MELOXICAM; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN SYNTHASE INHIBITOR; ROFECOXIB; SULINDAC; UNCLASSIFIED DRUG;

CELL PROTECTION; CLINICAL TRIAL; COLORECTAL TUMOR; DRUG MECHANISM; GASTROINTESTINAL TOXICITY; HUMAN; NEPHROTOXICITY; OSTEOARTHRITIS; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; STOMACH PROTECTION;

EID: 0030982146     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-0172(97)80046-7     Document Type: Article

References (78)

1. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin-like drugs Nature 231 1971 232 235
2. Higgs G.A. Vane J.R. Hart F.D. Wojtulewski J.A. Effects of anti-inflammatory drugs on prostaglandins in rheumatoid arthritis Robinson H.I. Vane J.R. Prostaglandin Synthase Inhibitors 1974 Raven 165 173
3. Hemler M. Lands W.E.M. Smith W.L. Purification of the cyclooxygenase that forms prostaglandins: Demonstration of two forms of iron in the holoenzyme J Biol Chem 251 1976 5575 5579
4. 2 synthase-1 Nature 367 1994 243 249
5. Luong C. Miller A. Barnett J. Chow J. Ramesha C. Browner M.E. Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2 Nat Struct Biol 3 1996 927 933
6. Gierse J.K. McDonald J.J. Hauser S.D. Rangwala S.H. Koboldt C.M. Seibert K. A single amino acid difference between cyclooxygenase-1 (COX-1) and −2 (COX-2) reverses the selectivity of COX-2 specific inhibitors J Biol Chem 271 1996 15810 15814
7. Moncada S. Gryglewski R. Bunting S. Vane J.R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation Nature 263 1976 663 665
8. Whittle B.J.R. Higgs G.A. Eakins K.E. Moncada S. Vane J.R. Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa Nature 284 1980 271 273
9. Funk C.D. Funk L.B. Kennedy M.E. Pong A.S. Fitzgerald G.A. Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment FASEB J 5 1991 2304 2312
10. Raz A. Wyche A. Needleman P. Temporal and pharmacological division of fibroblast cyclooxygenase expression into transcriptional and translational phases Proc Natl Acad Sci U S A 86 1989 1657 1661
11. Fu J.Y. Masferrer J.L. Seibert K. Raz A. Needleman P. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes J Biol Chem 265 1990 16737 16740
12. Masferrer J.L. Zweifel B.S. Seibert K. Needleman P. Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice J Clin Invest 86 1990 1375 1379
13. Xie W. Chipman J.G. Robertson D.L. Erikson R.L. Simmons D.L. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing Proc Natl Acad Sci U S A 88 1991 2692 2696
14. Xie W. Robertson D.L. Simmons D.L. Mitogen-inducible prostaglandin G/H synthase: a new target for nonsteroidal antiinflammatory drugs Drug Devel Res 25 1992 249 265
15. O'Banion M.K. Sadowski H.B. Winn V. Young D.A. A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein J Biol Chem 266 1991 23261 23267
16. Kujubu D.A. Fletcher B.S. Varnum B.C. Lim R.W. Herschman H.R. TIS 10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue J Biol Chem 26 1991 12866 12872
17. Sirois J. Richards I.S. Purification and characterization of a novel, distinct, isoform of prostaglandin endoperoxide synthase induced by human chorionic gonadotropin ingranulosa cells of rat preovulatory follicles J Biol Chem 267 1992 6382 6388
18. Vane J. Towards a better aspirin Nature 367 1994 215 216
19. DeWitt D.L. Prostaglandin endoperoxide synthase: Regulation of enzyme expression Biochim Biophys Acta 1083 1991 121 134
20. Wu K.K. Sanduja R. Tsai A.L. Ferhanoglu B. Loose-Mitchell D.S. Aspirin inhibits interleukin 1-induced prostaglandin H synthase expression in cultured endothelial cells Proc Natl Acad Sci U S A 88 1991 2384 2387
21. Whittle B.J.R. Vane J.R. Prostanoids as regulators of gastrointestinal function Johnston L.R. ed 2 Physiology of the Gastrointestinal Tract Vol I 1987 Raven New York 143 180
22. Kargman S. Charleson S. Cartwright M. Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey and human gastrointestinal tracts Gastroenterology 111 1996 445 454
23. Langenbach R. Morham S.G. Tiano H.E. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration Cell 83 1995 483 492
24. Kutchera W. Jones D.A. Matsunami N. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: Evidence for a transcriptional effect Proc Natl Acad Sci U S A 93 1996 4816 4820
25. Gustafson-Svard C. Lilja I. Hallbook O. Sjodahl R. Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats Gut 38 1996 79 84
26. Thun M.J. Namboodiri M.M. Heath C.W.J. Aspirin use and reduced risk of fatal colon cancer New Engl J Med 325 1991 1593 1596
27. Luk G.D. Prevention of gastrointestinal cancer-the potential role of NSAIDs in colorectal cancer Schweiz Med Wochenschr 126 1996 801 812
28. Nugent K.P. Spigelman A.D. Phillips R.K.S. Tissue prostaglandin levels in familial adenomatous polyposis patients treated with sulindac Dis Colon Rectum 39 1996 659 662
29. Stokes J.B. Effect of prostaglandin E2 on chloride transport across the rabbit thick ascending limb of Henle. Selective inhibitions of the medullary portion J Clin Invest 64 1979 495 502
30. Orloff J. Zusman R. Role of prostaglandin E (PGE) in the modulation of action of vasopressin on water flow in the urinary bladder of the toad and mammalian kidney J Membr Biol 40 1978 297 304
31. Harris R.C. McKanna J.A. Akai Y. Jacobson H.R. Dubois R.N. Greyer M.D. Cyclooxygenase-2 is associated with the macula dense of rat kidney and increases with salt restriction J Clin Invest 94 1994 2504 2510
32. Nusing R.M. Klein T. Pfeilschifter J. Ullrich V. Effect of cyclic AMP and prostaglandin E2 on the induction of nitric oxide- and prostanoid-forming pathways in cultured rat mesangial cells Biochem J 313 1996 617 623
33. Morham S.G. Langenbach R. Loftin C.D. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse Cell 83 1995 473 482
34. Hayaishi O. Molecular mechanisms of sleep-wake regulation: roles of prostaglandin D2 and E2 FASEB J 5 1991 2575 2581
35. Jones S.A. Adamson S.L. Bishai I. Lees J. Engelberts D. Coceani F. Eicosanoids in third ventricular cerebrospinal fluid of fetal and newborn sheep Am J Physiol 264 1993 R135 R142
36. Peri K.G. Hardy P. Li D.Y. Varma D.R. Chemtob S. Prostaglandin G/H synthase-2 is a major contributor of brain Prostaglandins in the newborn J Biol Chem 270 1995 2461 2520
37. Chemtob S. Beharry K. Rex J. Varma D.R. Aranda J.V. Prostanoids determine the range of cerebral blood flow autoreguiation of newborn piglets Stroke 21 1990 777 784
38. Yamagata K. Andreassson K.I. Kaufman W.E. Barnes C.A. Worley P.F. Expression of a mitogen-inducible cyclooxygenase in brain neurons; regulation by synaptic activity and glucocorticoids Neuron 11 1993 371 386
39. Breder C.D. Dewitt D. Kraig R.P. Characterization of inducible cyclooxygenase in rat brain J Comp Neurol 355 1995 296 315
40. Breder C.D. Saper C.B. Expression of inducible cyclooxygenase mRNA in the mouse brain after systemic administration of bacterial lipopolysaccharide Brain Res 713 1996 64 69
41. Cao C. Matsumura K. Yamagata K. Watanabe Y. Endothelial cells of the brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1,B: a possible site of prostaglandin synthesis responsible for fever Brain Res 733 1996 263 272
42. Cao C. Matsumura K. Yamagata K. Watanabe Y. Induction by lipopolysaccharide of cyclooxygenase-2 mRNA in rat brain; its possible role in the febrile response Brain Res 697 1995 187 196
43. Marcheselli V.L. Bazan N.G. Sustained induction of prostaglandin endoperoxide synthase-2 by seizures in hippocampus J Biol Chem 271 1996 24794 24799
44. Beiche F. Scheuerer S. Brune K. Geisslinger G. Goppelt-Struebe M. Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation FEBS Lett 390 1996 165 169
45. Milton A.S. Antipyretic actions of aspirin Vane J.R. Botting R.M. Aspirin and Other Salicylates 1992 Chapman & Hall London 213 244
46. Futaki N. Yoshikawa K. Hamasaka Y. NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects which causes minimal stomach lesions Gen Pharmacol 24 1993 105 110
47. and London: William Harvey Press Bennett P. Slater D. COX-2 expression in labour Vane J. Botting J. Botting R. Improved Non-steroid Antiinflammatory Drugs. COX-2 Enzyme Inhibitors 1996 Kluwer Academic Publishers Lancaster UK 167 188
48. Langenbach R. Morham S.G. Tiano H.F. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration Cell 83 1995 483 492
49. Gibb W. Sun M. Localization of prostaglandin H synthase type 2 protein and mRNA in term human fetal membranes and decidua J Endocrinol 150 1996 497 503
50. Trautman M.S. Edwin S.S. Collmer D. Dudley D.J. Simmons D. Mitchell M.D. Prostaglandin H synthase-2 in human gestational tissues: Regulation in amnion Placenta 17 1996 239 245
51. Toth P. Li X. Lei Z.M. Rao C.V. Expression of human chorionic gonadotropin (hCG)/iuteinizing hormone receptors and regulation of the cyclooxygenase-1 gene by exogenous hCG in human fetal membranes J Clin Endocrinol Metab 81 1996 1283 1288
52. Dinchuk J.E. Car B.D. Focht R.J. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 378 1995 406 409
53. Chakraborty I. Das S.K. Wang J. Dey S.K. Developmental expression of the cyclo-oxygenase-1 and cyclo-oxygenase-2 genes in the pert-implantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids J Mol Endocrinol 16 1996 107 122
54. Zakar T. Hirst J.J. Milovic J.E. Olson D.M. Glucocorticoids stimulate the expression of prostaglandin endoperoxide H synthase-2 in amnion cells Endocrinology 136 1995 1610 1619
55. Spaziani E.P. Lantz M.E. Benoit R.R. O'Brien W.E. The induction of cyclooxygenase-2 (COX-2) in intact human amnion tissue by interleukin-4 Prostaglandins 51 1996 215 223
56. McLaren W.J. Young I.R. Wong M.I.T. Rice G.E. Expression of prostaglandin G/H synthase-1 and -2 in ovine amnion and placenta following glucocorticoid-induced labour onset J Endocrinol 151 1996 125 135
57. García Rodríguez L.A. Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual nonsteroidal anti-inflammatory drugs Lancet 343 1994 769 772
58. Langman M.I.S. Weil J. Wainwright P. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs Lancet 343 1994 1075 1078
59. Henry D. Lim L.L.-Y. García Rodríguez L.A. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborativemeta-analysis Br Med J 312 1996 1563 1566
60. Vane J.R. Botting R.M. New insights into the mode of action of anti-inflammatory drugs Inflamm Res 44 1995 1 10
61. Mitchell J.A. Akarasereenont P. Thiemermann C. Flower R.J. Vane J.R. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase Proc Natl Acad Sci U S A 90 1993 11693 11697
62. Grossman C.J. Wiseman J. Lucas F.S. Trevethick M.A. Birch P.J. Inhibition of constitutive and inducible cyclooxygenase activity in human platelets and mononuclear cells by NSAIDs and Cox 2 inhibitors Inflamm Res 44 1995 253 257
63. Laneuville O. Breuer D.K. DeWitt D.L. Hla T. Funk C.D. Smith W.L. Differential inhibition of human prostaglandin endoperoxide H syntheses-I and -2 by nonsteroidal antiinflammatory drugs J Pharmacol Exp Ther 271 1994 927 934
64. Churchill L. Graham A.G. Shih C.K. Pauletti D. Farina P.R. Grob P.M. Selective inhibition of human cyclo-oxygenase-2 by meioxicam Inflammopharmacology 4 1996 125 135
65. Meade E.A. Smith W.L. DeWitt D.L. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs J Biol Chem 268 1993 6610 6614
66. Engelhardt G. Bogel R. Schnitzer Chr. Utzmann R. Meloxicam: influence on arachidonic acid metabolism. Part I. In vitro findings Biochem Pharmacol 51 1996 21 28
67. Klein T. Nusing R.M. Pfeilschifter J. Ullrich V. Selective inhibition of cyclooxygenase 2 Biochem Pharmacol 48 1994 1605 1610
68. Futaki N. Takahashi S. Yokoyama M. Arai S. Higuchi S. Otomo S. NS398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro Prostaglandins 47 1994 55 59
69. O'Neill G.P. Mancini J.A. Kargman S. Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal antiinflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid Mol Pharmacol 45 1994 245 254
70. Gierse J.K. Hauser S.D. Creely D.P. Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase Biochem J 305 1995 479 484
71. Patrignani P. Panara M.R. Greco A. Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide syntheses J Pharmacol Exp Ther 271 1994 1705 1712
72. Young J.M. Panah S. Satchawatcharaphong C. Cheung P.S. Human whole blood assays for inhibition of prostaglandin G/H syntheses-1 and -2 using A23187 and lipopolysaccharide stimulation of thromboxane B2production Inflamm Res 45 1996 246 253
73. (Abstract) Tavares I.A. Bennett A. Activity of nimesulide on constitutive and inducible prostaglandin cyclo-oxygenase Int J Tissue React 15 1993 49
74. Barner A. Review of clinical trials and benefit/risk ratio of meloxicam Scand J Rheumatol 25 Suppl 102 1996 29 37
75. Seibert K. Zhang Y. Leahy K. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain Proc Natl Acad Sci U S A 91 1994 12013 12017
76. Chan C.C. Boyce S. Brideau C. Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach J Pharmacol Exp Ther 274 1995 1531 1537
77. Hubbard R.C. Mehlisch D.R. Jasper D.R. Nugent M.J. Yu S. Isakson P.C. SC-58635, a highly selective inhibitor of COX-2, is an effective analgesic in an acute post-surgical pain model J Invest Med 44 1996 293A
78. Rabasseda X. Nimesulide: a selective cyclooxygenase 2 inhibitor anfiinflammatory drug Drugs of Today 33 Supp12 1997 1 25